Enhanced CICR activity reduces ER Ca2+ level in cells expressing CPVT-linked mutant RyR2
N. Kurebayashi, T. Murayama, R. Ohta, J. Suzuki, K. Kanemaru, S. Ohno, M. Horie, M. Iino, F. Yamashita, T. Sakurai
Abstract
Type 2 ryanodine receptor (RyR2) is a cardiac Ca2+ release channel in the endoplasmic reticulum (ER). Mutations in RyR2 are linked to catecholaminergic polymorphic ventricular tachycardia (CPVT), which is considered to be associated with enhanced spontaneous Ca2+ release. This spontaneous Ca2+ release tends to occur when ER Ca2+ ([Ca2+]ER) reaches a certain threshold level, and CPVT mutations are reported to lower this threshold. There are two explanations for this lowered threshold: the mutations increase sensitivity to luminal Ca2+ or they enhance cytosolic [Ca2+] ([Ca2+]cyt)-induced Ca2+ release (CICR) activity. However, no quantitative analysis of this issue has been performed so far. Here, we quantitatively explored how the change in CICR activity of RyR2 affects the threshold [Ca2+]ER experimentally and by model-based simulation. Wild-type (WT) and CPVT-linked mutant RyR2s were expressed in HEK293 cells. [Ca2+]cyt and [Ca2+]ER measurements with Ca2+ indicators revealed that CPVT RyR2 cells showed higher oscillation frequency and lower threshold [Ca2+]ER in a mutation-specific manner compared with WT cells. The CICR activity of mutant RyR2s was assessed by Ca2+-dependent [3H]ryanodine binding and parameter analysis. CICR activity at resting [Ca2+]cyt, A7.0, was higher in CPVT mutants than in WT and a strong inverse correlation was found between threshold [Ca2+]ER and A7.0. Interestingly, lowering RyR2 expression increased threshold [Ca2+]ER, suggesting that the threshold [Ca2+]ER depends on net Ca2+ release rate via RyR2, a product of A7.0 for each mutant and the density of RyR2 molecules. A model-based simulation successfully reproduced the [Ca2+]cyt and [Ca2+]ER changes. Interestingly, the CICR activity associated with specific mutations correlated well with the age of onset of the disease in CPVT patients carrying the mutations. Our data suggest that the reduction in threshold [Ca2+]ER for spontaneous Ca2+ release by CPVT mutation is explained by enhanced CICR activity without considering a change in the [Ca2+]ER sensitivity of RyR2. SummaryCPVT-linked RyR2 mutations are prone to induce spontaneous Ca2+ release from ER, which is strongly associated with arrhythmias. Kurebayashi et al. quantitatively explore how the changes in CICR activity by RyR2 mutations affect spontaneous Ca2+ experimentally and by model simulation.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Screening for novel RyR2 inhibitors by ER Ca2+ monitoring
M. Takenaka, M. Kodama, … N. Kurebayashi·bioRxiv·Aug 21, 2023
- Redefining catecholaminergic polymorphic ventricular tachycardia (CPVT) as a neurocardiac condition
Molly O’Reilly, Arie O. Verkerk, Carol Ann Remme·bioRxiv·Jan 27, 2025
- A novel RyR2-selective stabilizer prevents stress-induced ventricular arrhythmias without impairing cardiac function
Nagomi Kurebayashi, Masami Kodama, … Takashi Sakurai·British Journal of PharmacologyPeer-reviewed·Apr 27, 2026
- Location of ryanodine receptor type 2 mutation predicts age of onset of sudden death in catecholaminergic polymorphic ventricular tachycardia. A systematic review and meta analysis of case based literature
Halil Beqaj, Leah R. Sittenfeld, … Andrew R. Marks·medRxiv·Mar 15, 2024
- Structural basis for Ca2+-dependent allosteric modulation of cardiac ryanodine receptor by Ryanozole
Yuya Otori, Takashi Murayama, … Haruo Ogawa·bioRxiv·May 23, 2026
- CaMKII Phosphorylation of RyR2 is Essential for Arrhythmia in CPVT
Sofia De La Serna Buzón, Xiaoting Wang, … Vassilios J. Bezzerides·bioRxiv·Sep 15, 2025